Literature DB >> 8227894

The effects of age and diabetes mellitus on nerve function.

R E Maser1, C Laudadio, G S DeCherney.   

Abstract

OBJECTIVE: This project evaluated the association of age and vibratory thresholds (assessment modality of large sensory nerve fibers) in subjects with and without diabetes mellitus.
DESIGN: Cross-sectional study.
SETTING: Medical Research Institute of Delaware. PARTICIPANTS: Individuals with non-insulin-dependent diabetes mellitus and non-diabetic control subjects. MEASUREMENTS: Vibratory thresholds were examined in four age groups (ie, < 45 yrs, 45-54 yrs, 55-64 yrs, > or = 65 yrs). The independent association of age, duration of diabetes, height, gender, glycemic control, and smoking history were analyzed in terms of their relationship to vibratory thresholds. MAIN
RESULTS: Vibratory thresholds increased with age for both control and diabetic subjects. Comparing controls with diabetic subjects in the same age categorizes revealed significant differences for vibratory thresholds only in the > or = 65 year old age group. Modeling with vibratory thresholds as the dependent variable showed that age and male gender were independently associated with vibratory thresholds for the controls and explained the majority of the variability (R2 = 0.79). Age, duration of diabetes, and height were independently associated with vibratory thresholds for the diabetic subjects but explained much less of the variability (R2 = 0.39).
CONCLUSIONS: The results suggest an acceleration of the natural aging process for large sensory nerve fiber function in diabetic subjects. Thus, young diabetic subjects may be at a risk of lower extremity complications as a result of injuries similar to that older non-diabetic individuals.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8227894     DOI: 10.1111/j.1532-5415.1993.tb07303.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  5 in total

1.  Prevalence of lower-extremity amputation among patients with diabetes mellitus: is height a factor?

Authors:  Chin-Hsiao Tseng
Journal:  CMAJ       Date:  2006-01-31       Impact factor: 8.262

Review 2.  Diabetic neuropathy in elderly patients. What can be done?

Authors:  J Belmin; P Valensi
Journal:  Drugs Aging       Date:  1996-06       Impact factor: 3.923

3.  Peripheral sensory neuropathy associates with micro- or macroangiopathy: results from a population-based study of type 2 diabetic patients in Sweden.

Authors:  Lars Kärvestedt; Eva Mårtensson; Valdemar Grill; Stig Elofsson; Gunvor von Wendt; Anders Hamsten; Kerstin Brismar
Journal:  Diabetes Care       Date:  2008-11-25       Impact factor: 17.152

4.  Lipoprotein(a) serum levels in diabetic patients with retinopathy.

Authors:  Giulia Malaguarnera; Caterina Gagliano; Claudio Bucolo; Marco Vacante; Salvatore Salomone; Michele Malaguarnera; Daniela Giovanna Leonardi; Massimo Motta; Filippo Drago; Teresio Avitabile
Journal:  Biomed Res Int       Date:  2013-06-05       Impact factor: 3.411

5.  Stratified analyses for selecting appropriate target patients with diabetic peripheral neuropathy for long-term treatment with an aldose reductase inhibitor, epalrestat.

Authors:  N Hotta; R Kawamori; Y Atsumi; M Baba; H Kishikawa; J Nakamura; S Oikawa; N Yamada; H Yasuda; Y Shigeta
Journal:  Diabet Med       Date:  2008-07       Impact factor: 4.359

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.